Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas-Implication for clinical evaluation of cancer patient

Cytokine

Volumn 41, Issue 3, 2008, Pages 232-239

  Krzystek Korpacka, Malgorzata ^a   Matusiewicz, Malgorzata ^a   Diakowska, Dorota ^a   Grabowski, Krzysztof ^a   Blachut, Katarzyna ^b   Konieczny, Dariusz ^c   Kustrzeba Wojcicka, Irena ^a   Terlecki, Grzegorz ^a   Banas, Teresa ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Department of Gastroenterology and Hepatology   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Esophageal squamous cell carcinoma (ESCC); Interleukin 8 (IL 8); Lymph node metastasis; Vascular endothelial growth factor A (VEGF A); Vascular endothelial growth factor C (VEGF C)

Indexed keywords

INTERLEUKIN 8; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-8; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 39749126230     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.11.011     Document Type: Article

References (41)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics. CA Cancer J Clin 55 (2005) 10-30
2. Tew W.P., Kelsen D.P., and Ilson D.H. Targeted therapies for esophageal cancer. Oncologist 10 (2005) 590-601
3. Aurello P., D'Angelo F., Nigri G., Bellagamba R., Cicchini C., Ruzzetti R., et al. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review. Am Surg 72 (2006) 118-123
4. Tammela T., Heckman C., and Alitalo K. Lymphangiogenesis and metastasis. Am Assoc Cancer Res Educ Book 2005 (2005) 67-73
5. Lee S.J., Lee K.S., Yim Y.J., Kim T.S., Shim Y.M., and Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol 60 (2005) 547-554
6. Lerut T., Coosemans W., Decker G., De Leyn P., Moons J., Nafteux P., et al. Surgical techniques. J Surg Oncol 92 (2005) 218-229
7. Sasano H., and Suzuki T. Pathological evaluation of angiogenesis in human tumor. Biomed Pharmacother 59 (2005) S334-S336
8. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., and Belperio J.A. Cancer CXC chemokine networks and tumor angiogenesis. Eur J Cancer 42 (2006) 768-778
9. Macri A., Versaci A., Loddo S., Scuderi G., Travagliante M., Trimarchi G., et al. Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers 11 (2006) 184-193
10. Ren Y., Poon R.T., Tsui H.T., Chen W.H., Li Z., Lau C., et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9 (2003) 5996-6001
11. Kitadai Y., Onogawa S., Kuwai T., Matsumura S., Hamada H., Ito M., et al. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 11 (2004) 315-319
12. Ren Y., Law S., Huang X., Lee P.Y., Bacher M., Srivastava G., et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242 (2005) 55-63
13. Ren Y., Cao B., Law S., Xie Y., Lee P.Y., Cheung L., et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 11 (2005) 6190-6197
14. Benoy I.H., Salgado R., Van Dam P., Geboers K., Van Marck E., Scharpe S., et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10 (2004) 7157-7162
15. Gokhale A.S., Haddad R.I., Cavacini L.A., Wirth L., Weeks L., Hallar M., et al. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 41 (2005) 70-76
16. Kaminska J., Nowacki M.P., Kowalska M., Rysinska A., Chwalinski M., Fuksiewicz M., et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I-an independent prognostic factor. Tumour Biol 26 (2005) 186-194
17. He Y., Karpanen T., and Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochem Biophys Acta 1654 (2004) 3-12
18. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. 6th ed. (2002), John Wiley & Sons, Hoeboken, New Jersey
19. Bruns D.E., Huth E.J., Magid E., and Young D.S. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 46 (2000) 893-895
20. Lambert R. Esophageal cancer. World Gastroenterol News 11 (2006) 37-39
21. Orditura M., De Vita F., Catalano G., Infusino S., Lieto E., Martinelli E., et al. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. J Interferon Cytokine Res 22 (2002) 1129-1135
22. Konno H., Ohta M., Baba M., Suzuki S., and Nakamura S. The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci 94 (2003) 735-740
23. Lee K.H., Bae S.H., Lee J.L., Hyun M.S., Kim S.H., Song S.K., et al. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Oncology 66 (2004) 210-217
24. Chen J.J., Yao P.L., Yuan A., Hong T.M., Shun C.T., Kuo M.L., et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 9 (2003) 729-737
25. Smyth M.J., Zachariae C.O., Norihisa Y., Ortaldo J.R., Hishinuma A., and Matsushima K. IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol 146 (1991) 3815-3823
26. Li A., Varney M.L., Valasek J., Godfrey M., Dave B.J., and Singh R.K. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8 (2005) 63-71
27. Gomperts B.N., and Strieter R.M. CXC chemokines in angiogenesis and metastasis. Am Assoc Cancer Res Educ Book 2006 (2006) 11-17
28. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., Grabowski K., Blachut K., and Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett 249 (2007) 171-177
29. Kuwada Y., Sasaki T., Morinaka K., Kitadai Y., Mukaida N., and Chayama K. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int J Oncol 22 (2003) 765-771
30. Kleespies A., Bruns C.J., and Jauch K.W. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies. Onkologie 28 (2005) 281-288
31. Achen M.G., and Stacker S.A. Tumor lymphangiogenesis and metastatic spread-New players begin to emerge. Int J Cancer 119 (2006) 1755-1760
32. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., and Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201 (2005) 1089-1099
33. Ristimaki A., Narko K., Enholm B., Jaoukov V., and Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273 (1998) 8413-8418
34. Tamura M., Oda M., Tsunezuka Y., Matsumoto I., Kawakami K., and Ohta Y. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 126 (2004) 342-346
35. Matsumoto M., Natsugoe S., Okumura H., Arima H., Yanagita S., and Uchikado Y. Overexpression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer. J Gastrointest Surg 10 (2006) 1016-1022
36. Kosugi S., Nishimaki T., Kanda T., Nakagawa S., Ohashi M., and Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 28 (2004) 680-685
37. Mealy K., Feely J., Reid I., McSweeney J., Walsh T., and Hennessy T.P.J. Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 22 (1996) 505-507
38. Shimada Y., Watanabe G., Kawamura J., Soma T., Okabe M., Ito T., et al. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology 68 (2005) 285-292
39. Sato T., Iizuka N., Hamamoto Y., Yoshino S., Abe T., Takeda S., et al. Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. Int J Oncol 28 (2006) 1043-1055
40. Boldrini L., Gisfredi S., Ursino S., Lucchi M., Mussi A., Basolo F., et al. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Lung Cancer 50 (2005) 309-317
41. Wigmore S.J., Fearon K.C., Sangster K., Maingay J.P., Garden O.J., and Ross J.A. Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21 (2002) 881-886